Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

Fountain Life Acquires LifeOmic to Optimize Preventative Care

What You Should Know: – Fountain Life, a leader in advanced diagnostics and preventative healthcare, has acquired LifeOmic, a health data technology company specializing in

December 6, 2023

Novo unveils new cardiometabolic data as it reports solid third-quarter profits

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 7, 2024

Watch: What we know about traces of H5N1 bird flu found in pasteurized milk

Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and Drug Administration. The

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.